BioCryst to Report Second Quarter 2026 Financial Results on August 5
Go back to BioCryst to Report Second Quarter 2026 Financial Results on August 5| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 9.38 -0.13 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.51 | 52 Week High | $10.98 | |||
| Open | $9.32 | 52 Week Low | $1.63 | |||
| Day High | $9.48 | P/E | N/A | |||
| Day Low | $9.25 | EPS | $-0.68 | |||
| Volume | 1,635,329 | |||||
